Skip to main content
Intracranial Pressure (ICP) Monitoring Devices Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, China, Japan - Size and Forecast 2024-2028

Intracranial Pressure (ICP) Monitoring Devices Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, China, Japan - Size and Forecast 2024-2028

Published: Jul 2024 155 Pages SKU: IRTNTR73001

Market Overview at a Glance

$632.4 Mn
Market Opportunity
6.78%
CAGR
6.24
YoY growth 2023-2024(%)

Intracranial Pressure (ICP) Monitoring Devices Market Size 2024-2028 

The intracranial pressure (ICP) monitoring devices market size is forecast to increase by USD 632.4 billion at a CAGR of 6.78% between 2023 and 2028. The market is experiencing significant growth due to several key factors. Firstly, the increasing number of product launches is driving market expansion. Secondly, advancements in technology are enhancing the capabilities of ICP monitoring devices, making them more effective and accurate. However, the use of invasive methods, such as skull catheters placed in the ventricular space, carries risks and complications, which can hinder market growth. Neurology specialists continue to rely on neuromonitoring and neurodiagnostic solutions to assess ICP and optimize patient care. Furthermore, the integration of advanced tools like surgical microscopes, neurosurgery devices, and ophthalmic surgical devices, as well as surgical robots, is revolutionizing neurosurgical procedures and increasing the demand for ICP monitoring devices. Despite the challenges, the market is expected to continue growing due to the critical role these devices play in neurodiagnostics and neurosurgery.

What will be the Size of the Market During the Forecast Period?

Intracranial Pressure (ICP) Monitoring Devices Market Size

 Request Free Sample

The market refers to the segment supplying instruments used to assess and manage the pressure within the skull, particularly in patients with conditions affecting the cerebrospinal fluid (CSF) and brain tissue. These conditions include traumatic brain injury, intracranial aneurysms, idiopathic intracranial hypertension, and strokes. ICP monitoring plays a crucial role in understanding the pathophysiology of various neurological disorders. The devices enable specialists to monitor the pressure within the cranium, which can help diagnose and manage intracranial hypertension therapy. Invasive methods for ICP monitoring involve the insertion of a catheter into the ventricular space or the skull to directly measure pressure.

Furthermore, non-invasive techniques, on the other hand, utilize external pressure transducers and non-invasive neuroimaging modalities like otoacoustic emission, pupillometry, and transcranial Doppler ultrasonography. The geriatric population is a significant target demographic for ICP monitoring devices due to the increased prevalence of neurological conditions in this age group. Space medical applications also require ICP monitoring to ensure astronauts' safety during space travel. Intracranial hypertension can lead to various complications, including damage to the cerebral ventricles and brain parenchyma. ICP monitoring devices help specialists administer drugs to alleviate the condition and prevent further damage. Magnetic resonance imaging (MRI) and electroencephalography (EEG) are often used in conjunction with ICP monitoring to provide a more comprehensive understanding of the patient's condition.

Moreover, artificial intelligence (AI) and data analytics are increasingly being integrated into ICP monitoring devices to improve accuracy and efficiency. For instance, AI algorithms can analyze CSF flow patterns and identify potential complications before they become clinically significant. Additionally, non-invasive techniques like acoustic sound detection and otoacoustic emission analysis can be enhanced with AI-powered analysis. In summary, the intracranial pressure monitoring devices market caters to the demand for advanced tools that enable healthcare professionals to assess and manage intracranial pressure in various neurological conditions. The market includes invasive and non-invasive devices, with a growing emphasis on AI and data analytics to improve diagnostic accuracy and patient outcomes.

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

  • Product
    • Invasive
    • Non-invasive
  • Application
    • Traumatic brain injury
    • Intracerebral hemorrhage
    • Others
  • Geography
    • North America
      • US
    • Europe
      • Germany
      • UK
    • Asia
      • China
      • Japan
    • Rest of World (ROW)

By Product Insights

The invasive segment is estimated to witness significant growth during the forecast period. Intracranial pressure (ICP) monitoring devices are essential medical tools used to assess and manage increased pressure within the skull. These devices are implemented through invasive techniques, which involve inserting a catheter into the brain parenchyma or ventricles to measure ICP. Three primary methods exist for implanting ICP monitoring devices: intraventricular catheters, subdural screws, and epidural sensors. Among these, intraventricular catheters provide the most accurate results due to their direct contact with the cerebrospinal fluid (CSF) in the ventricles. Intraventricular catheters are utilized for both monitoring ICP and intermittently extracting excess CSF when necessary. In contrast, subdural screws involve drilling a hole in the skull to place a device with a sensor fitted on its surface.

Furthermore, ICP monitoring using these devices is crucial for managing conditions such as hemorrhage, infection, malfunction, obstruction, mispositioning, and stroke. Despite their benefits, complications like infection, hemorrhage, malfunction, and mispositioning can occur. Ensuring proper placement and maintenance of these devices is essential to minimize risks and optimize patient outcomes. In summary, intracranial pressure monitoring devices play a vital role in managing various neurological conditions. Invasive techniques, primarily intraventricular catheters, offer the most accurate results for ICP monitoring and CSF management. Proper placement, maintenance, and timely intervention in case of complications are crucial to optimize patient outcomes.

Intracranial Pressure (ICP) Monitoring Devices Market Size

Get a glance at the market share of various segments Request Free Sample

The Invasive segment accounted for USD 694.50 million in 2018 and showed a gradual increase during the forecast period.

Regional Insights

North America is estimated to contribute 45% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

Intracranial Pressure (ICP) Monitoring Devices Market Share by Geography

For more insights on the market share of various regions Request Free Sample

The Intracranial pressure monitoring devices market in North America is anticipated to expand at a steady pace over the upcoming years. In 2023, North America held a significant share of the global ICP monitoring devices market. The presence of major players such as Integra LifeSciences and Natus Medical, based in the US, significantly contributes to the market's growth. These companies offer a broad range of products, catering to various medical requirements, thereby fueling the regional market expansion. Traumatic Brain Injury (TBI) and intracranial aneurysms are common conditions leading to increased demand for ICP monitoring devices. These conditions can result in elevated cerebrospinal fluid pressure, which, if left untreated, can lead to severe health complications.

Further, cerebral ventricles, cerebral parenchyma, and cranium diameter are essential parameters monitored using these devices. Advanced diagnostic techniques, such as otoacoustic emission, pupillometry, ophthalmoscopy, magnetic resonance imaging (MRI), and electroencephalography (EEG), are used in conjunction with ICP monitoring devices for accurate diagnosis and treatment planning. The geriatric population, who are more susceptible to TBI and intracranial aneurysms, further boosts the market's growth. In summary, the Intracranial pressure monitoring devices market in North America is poised for steady growth, driven by the presence of major players, increasing incidence of TBI and intracranial aneurysms, and advanced diagnostic techniques.

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Market Driver

Increased product launches is the key driver of the market. The intracranial pressure (ICP) monitoring market is witnessing significant advancements with companies introducing new and enhanced products to cater to diverse patient needs. Some recent developments in this market include the utilization of innovative technologies such as Near-Infrared Spectroscopy, Computed Tomography, External Ventricular Drainage, Microtransducer ICP Monitoring, Transcranial Doppler Ultrasonography, and more.

For instance, IRRAS AB recently announced the first use of its Hummingbird Solo ICP monitoring system in Mexico. This single-lumen, bolt-based monitor measures brain tissue pressure and assists in diagnosing and managing intracranial pressure in patients following traumatic brain injury, subarachnoid hemorrhage, intracerebral hemorrhage, hydrocephalus, cerebral edema, malignant cerebral infarction, and CNS infections. Ambulatory surgical centers also benefit from these advanced ICP monitoring devices, enabling early detection and effective treatment of intracranial pressure-related conditions.

Market Trends

Rising advances in technology is the upcoming trend in the market. companies in the market are introducing advanced technologies to create next-generation products. For example, Branchpoint Technologies provides the FDA-approved AURA intracranial pressure monitoring system. This system features fully implantable wireless intracranial pressure sensors, allowing for mobile monitoring of brain-injured patients. In contrast, traditional ICP monitoring systems rely on cabled connections attached to the patient's skull and ventricular space. The AURA system is completely wireless in terms of power and data transmission, with patient data displayed directly through a bedside monitor.

Furthermore, it offers continuous telemetric monitoring of parenteral intracranial pressure. Neurospecialists can utilize neuromonitoring and neurodiagnostic solutions, such as surgical microscopes, neurosurgery devices, and ophthalmic surgical devices, in conjunction with ICP monitoring systems to enhance patient care. Surgical robots can also be employed to assist in complex neurosurgical procedures. By employing these technologies, healthcare providers can ensure accurate and timely ICP monitoring, ultimately improving patient outcomes.

Market Challenge

Complications associated with ICP monitoring devices is a key challenge affecting the market growth. The intracranial pressure monitoring devices market in the United States has experienced moderate growth due to the complexities involved in the application of these devices. Complications arising from their use, such as bleeding, brain herniation, tissue damage, surgical site infections, and anesthesia risks, have posed challenges to market expansion. Various intracranial pressure monitoring methods are employed, including the use of an external ventricular drainage (EVD) system, which involves surgically inserting a catheter into the brain's ventricles.

Further, Neurotrauma and neurosurgical centers, as well as Intensive Care Unit (ICU) settings, are primary users of these devices for managing conditions like traumatic brain injury, cerebral amyloid angiopathy, migraines, obesity-related intracranial hypertension, and neurological disorders. Intracranial pressure monitoring plays a crucial role in intracranial hypertension therapy and has potential applications in space medicine. To ensure accurate and effective monitoring, it is essential to adhere to the best practices in the use of these devices and maintain a sterile environment to minimize complications.

Exclusive Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Intracranial Pressure (ICP) Monitoring Devices Market Share by Geography

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Integra Lifesciences Holdings Corp: The company offers different types of intracranial pressure monitoring devices especially Licox Monitor, and ICP Express.

The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

  • brain4care
  • Integra Lifesciences Corp.
  • IRRAS AB
  • Medtronic Plc
  • Natus Medical Inc.
  • Nisonic AS
  • RAUMEDIC AG
  • REHAU Ltd.
  • Sophysa
  • Spiegelberg GmbH and Co. KG
  • Tokibo Co. Ltd.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Research Analyst Overview

Intracranial pressure (ICP) monitoring devices play a crucial role in managing various neurological conditions, including traumatic brain injury, intracranial aneurysms, subarachnoid hemorrhage, intracerebral hemorrhage, hydrocephalus, cerebral edema, malignant cerebral infarction, CNS infections, and intraparenchymal pressure monitor for migraines. These conditions can lead to intracranial hypertension, which requires continuous surveillance to prevent secondary brain damage. Neurodiagnostic solutions, such as ophthalmoscopy, pupillometry, and venous ophthalmodynamometry, provide non-invasive methods for ICP assessment. However, invasive techniques, like microtransducer ICP monitoring and external ventricular drainage, offer real-time data for better patient management and treatment. The geriatric population is a significant user group for ICP monitoring devices due to the higher prevalence of neurological disorders and increased ICU utilization.

Further, Neurological conditions like cerebral amyotrophic lateral sclerosis, cerebral amyloid angiopathy, and obesity also necessitate ICP monitoring. ICP monitoring devices are essential in neurosurgery centers, trauma centers, and ambulatory surgical centers. Neurosurgical devices, such as surgical microscopes, surgical robots, and 3D imaging, are often used in conjunction with ICP monitoring systems for effective treatment. Continuous ICP monitoring enables early detection and treatment of complications like infection, hemorrhage, malfunction, obstruction, mispositioning, and stroke. Calibration techniques and telemedicine enable remote patient monitoring, enhancing the accessibility and affordability of ICP monitoring. Artificial intelligence and data analytics are increasingly being integrated into ICP monitoring devices to improve patient outcomes and streamline healthcare provider workflows.

Market Scope

Report Coverage

Details

Page number

155

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 6.78%

Market growth 2024-2028

USD 632.4 million

Market structure

Concentrated

YoY growth 2023-2024(%)

6.24

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 45%

Key countries

US, Germany, UK, China, and Japan

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

brain4care, Integra Lifesciences Corp., IRRAS AB, Medtronic Plc, Natus Medical Inc., Nisonic AS, RAUMEDIC AG, REHAU Ltd., Sophysa, Spiegelberg GmbH and Co. KG, and Tokibo Co. Ltd.

Market dynamics

Parent market analysis, market growth inducers and obstacles, market forecast, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, market condition analysis for the forecast period

Customization purview

If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request Free Sample

What are the Key Data Covered in this Market Research and Growth Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
  • Precise estimation of the size of the market  and its contribution of the market in focus to the parent market
  • Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market's competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents not available.

Research Methodology

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

Interested in this report?

Get your sample now to see our research methodology and insights!

Download Now

Frequently Asked Questions

Intracranial Pressure (ICP) Monitoring Devices market growth will increase by $ 632.4 mn during 2024-2028.

The Intracranial Pressure (ICP) Monitoring Devices market is expected to grow at a CAGR of 6.78% during 2024-2028.

Intracranial Pressure (ICP) Monitoring Devices market is segmented by Product( Invasive, Non-invasive) Application( Traumatic brain injury, Intracerebral hemorrhage, Others, Rest of World (ROW))

brain4care, Integra Lifesciences Corp., IRRAS AB, Medtronic Plc, Natus Medical Inc., Nisonic AS, RAUMEDIC AG, REHAU Ltd., Sophysa, Spiegelberg GmbH and Co. KG, Tokibo Co. Ltd. are a few of the key vendors in the Intracranial Pressure (ICP) Monitoring Devices market.

North America will register the highest growth rate of 45% among the other regions. Therefore, the Intracranial Pressure (ICP) Monitoring Devices market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

US, Germany, UK, China, Japan

  • Increased product launchesProduct launches help companies in expanding their offering ranges and penetrate various regions to strengthen their market presence. The competition among vendors results in the launch of increased and improved products. Some of the recent developments in the global ICP  monitoring market include the following: In August 2020 is the driving factor this market.
  • IRRAS AB announced that the first patient was treated using the company's Hummingbird Solo intracranial pressure Monitoring system in Mexico. The Hummingbird Solo is a single-lumen is the driving factor this market.
  • bolt-based monitor that measures the pressure within a patient's brain tissue. It helps diagnose and manage patients' intracranial pressure after TBI is the driving factor this market.
  • a subarachnoid hemorrhage is the driving factor this market.
  • or a stroke. The device was launched in the US in February 2020. In March 2020 is the driving factor this market.
  • Medtronic is the driving factor this market.
  • Inc. announced that the company had received approval from the FDA for its Medtronic external drainage and monitoring system. The device is used to monitor CSF in the ventricular or lumbar areas of the brain. It is used for the management of short-term external CSF drainage. In February 2020 is the driving factor this market.
  • Medtronic is the driving factor this market.
  • Inc. announced that the company had received approval from the FDA for its Becker external drainage and monitoring system. The device is used to drain and monitor CSF flow from the patient's lateral ventricles or the lumbar subarachnoid space to reduce intracranial pressure. The device can be used preoperatively is the driving factor this market.
  • intraoperatively is the driving factor this market.
  • and postoperatively to monitor CSF. With an increasing number of product approvals for both invasive and non-invasive ICP  monitoring devices is the driving factor this market.
  • the product portfolios of companies will grow. This will boost the growth of the global  Intracranial pressure monitoring devices market during the forecast period. is the driving factor this market.

The Intracranial Pressure (ICP) Monitoring Devices market vendors should focus on grabbing business opportunities from the Invasive segment as it accounted for the largest market share in the base year.